Therapeutic Vaccine Strategies against Human Papillomavirus

High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by viral oncoproteins. These are essential for the induction and maintenance of the malignant phenotype. Thus, HPV-mediated ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Khallouf, Hadeel, Grabowska, Agnieszka K., Riemer, Angelika B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494257/
https://www.ncbi.nlm.nih.gov/pubmed/26344626
http://dx.doi.org/10.3390/vaccines2020422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494257/
https://www.ncbi.nlm.nih.gov/pubmed/26344626
http://dx.doi.org/10.3390/vaccines2020422

Ejemplares similares